Publikationen
Wichtige Publikationen des CCC Münchens der letzten 5 Jahre
Braitsch, K., Lorenzini, T., Hefter, M., Koch, K., Nickel, K., et al. (2025). CXCR4-directed endoradiotherapy with [177Lu]Pentixather added to total body irradiation for myeloablative conditioning in patients with relapsed/refractory acute myeloid leukemia. Theranostics. 1838-7640.
Falcomatà, C., Bärthel, S., Widholz S.A., Schneeweis, C., Montero J., et al. (2022). Selective multi-kinase inhibition sensitizes mesenchymal pancreatic cancer to immune checkpoint blockade by remodeling the tumor microenvironment. Nat Cancer. 318-336.
Fey, T., Kasprzak, J., Ernst, J., Weiher, F., Schmid, M. et al. (2025). "Information and support for cancer patients and their relatives - evaluation of central contract point enquiries: a retrosprective analysis. BMC Health 1192.
Hager, P., Jungmann, F., Holland, R., Bhagat, K., Hubrecht, I., et al. (2024). Evaluation and mitigation of the limitations of large language models in clinical decision-making. Nat Med. 2613-2622.
Möhrmann, L, Werner, M., Oles`M., Mock, A., Uhrig, S., Jahn, et al. (2022). Comprehensive genomic and epigenomic analysis in cancer of unknown primary guides molecularly-informed therapies despite heterogeneity. Nat Commun. 4485.
Papargyriou, A., Najajreh, M., Cook, D., Maurer, C., Bärthel, S., et al. (2025). Heterogeneity-driven phenotypic plasticity and treatment response in branched-organoid models of pancreatic ductal adenocarcinoma. Nat Biomed Eng. 836-864.
Rieger, L., Irlinger, K., Füchsl, F., Tietje, M., Purcarea, A., et al. (2026). Boosting CAR T-cell efficacy by blocking proteasomal degradation of membrane antigens. Blood. 534-546.
Tejada-Lapuerta, A., Schaar, A.C., Gutgesell, R., Palla, G., et al. (2025). Nicheformer: a foundation model for single-cell and spatial omics. Nat Methods. 2525-2538.
Wartewig, T., Daniels, J., Schulz, M., Hameister, E. Joshi, A., et al. (2023). PD-1 instructs a tumor-suppressive metabolic program that restricts glycolysis and restrains AP-1 activity in T cell lymphoma. Nat Cancer. 1508-1525.